Business Description
Elutia Inc
NAICS : 339112
SIC : 5047
ISIN : US05479K1060
Share Class Description:
ELUT: Ordinary Shares - Class ATotal Employee Number:
26Description
Elutia Inc develops proprietary drug-eluting biomatrix products for use in surgical reconstruction and related applications. These products are designed to improve the interaction between implanted medical devices and patients. Its products include CanGaroo, designed for implantable electronic devices, and SimpliDerm, used in soft tissue repair, with functions related to implant support and wound management. The company operates in two segments: Women's Health and Cardiovascular. The majority of revenue is derived from the Women's Health segment.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 6.75 | |||||
Equity-to-Asset | 0.41 | |||||
Debt-to-Equity | 0.19 | |||||
Debt-to-EBITDA | -0.23 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | -4.47 | |||||
Beneish M-Score | 5.68 | |||||
WACC vs ROIC | ||||||
Growth Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -46.2 | |||||
3-Year EBITDA Growth Rate | 44.4 | |||||
3-Year EPS without NRI Growth Rate | 32.2 | |||||
3-Year FCF Growth Rate | 13.8 |
Momentum Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 39.39 | |||||
9-Day RSI | 42.22 | |||||
14-Day RSI | 43.4 | |||||
3-1 Month Momentum % | -2.75 | |||||
6-1 Month Momentum % | 53.02 | |||||
12-1 Month Momentum % | -50.23 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 2.05 | |||||
Quick Ratio | 1.94 | |||||
Cash Ratio | 1.2 | |||||
Days Inventory | 167.13 | |||||
Days Sales Outstanding | 61.09 | |||||
Days Payable | 256.94 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -53.5 | |||||
Shareholder Yield % | 17.63 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 54.02 | |||||
Operating Margin % | -134.36 | |||||
Net Margin % | 312.09 | |||||
EBITDA Margin % | -115.9 | |||||
FCF Margin % | -286.88 | |||||
OCF Margin % | -274 | |||||
ROE % | Neg. Equity | |||||
ROA % | 113.22 | |||||
ROIC % | -69.52 | |||||
3-Year ROIIC % | -42.68 | |||||
ROC (Joel Greenblatt) % | -467.84 | |||||
ROCE % | -185.31 | |||||
Years of Profitability over Past 10-Year | 1 | |||||
Moat Score | 3 | |||||
Tariff Resilience Score | 5 |
GF Value Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 1.1 | |||||
Price-to-Owner-Earnings | 1.18 | |||||
PS Ratio | 2.72 | |||||
PB Ratio | 1.85 | |||||
Price-to-Tangible-Book | 1.97 | |||||
EV-to-EBIT | -0.86 | |||||
EV-to-EBITDA | -0.94 | |||||
EV-to-Revenue | 1.09 | |||||
EV-to-FCF | -0.38 | |||||
Price-to-GF-Value | 1.04 | |||||
| Price-to-Net-Current-Asset-Value | 2.62 | |||||
Earnings Yield (Greenblatt) % | -116.28 | |||||
FCF Yield % | -109.78 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:ELUT
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Elutia Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 15.971 | ||
| EPS (TTM) ($) | 0.86 | ||
| Beta | 2.3329 | ||
| 3-Year Sharpe Ratio | 0.19 | ||
| 3-Year Sortino Ratio | 0.32 | ||
| Volatility % | 95.68 | ||
| 14-Day RSI | 43.4 | ||
| 14-Day ATR ($) | 0.076256 | ||
| 20-Day SMA ($) | 0.988215 | ||
| 12-1 Month Momentum % | -50.23 | ||
| 52-Week Range ($) | 0.5 - 2.64 | ||
| Shares Outstanding (Mil) | 44.21 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Elutia Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Elutia Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| Third quarter earnings conference call for 2026 | 2026-11-06 17:00 | In 128 days | ||
| Third quarter earnings results for 2026 | 2026-11-06 | In 127 days | ||
| Second quarter earnings conference call for 2026 | 2026-08-14 17:00 | In 44 days | ||
| Second quarter earnings results for 2026 | 2026-08-14 | In 43 days | ||
| Guidance call for 2026 | 2026-06-17 14:00 | 0.95 (-2.07%) | ||
| General meeting for 2026 | 2026-06-11 13:00 | 1.04 (+9.47%) | ||
| 16th Annual LD Micro Invitational | 2026-05-18 11:30 | 1.05 (+5.00%) | ||
| First quarter earnings conference call for 2026 | 2026-05-14 17:00 | 1.05 (-1.95%) | ||
| First quarter earnings results for 2026 | 2026-05-14 | 1.05 (-1.95%) | ||
| Sidoti\'s March Small-cap Virtual Conference | 2026-03-19 14:30 | 1.08 (-4.42%) |
Show
Entries
Elutia Inc Frequently Asked Questions
What is Elutia Inc(ELUT)'s stock price today?
The current price of ELUT is $0.94. The 52 week high of ELUT is $2.64 and 52 week low is $0.50.
When is next earnings date of Elutia Inc(ELUT)?
The next earnings date of Elutia Inc(ELUT) is 2026-08-14 Est..
Does Elutia Inc(ELUT) pay dividends? If so, how much?
Elutia Inc(ELUT) does not pay dividend.
Guru Commentaries on NAS:ELUT
No articles.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Elutia Inc
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers